Page last updated: 2024-08-21

quinazolines and bis(1,3-diethylthiobarbiturate)trimethineoxonol

quinazolines has been researched along with bis(1,3-diethylthiobarbiturate)trimethineoxonol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amoroso, S; Annunziato, L; Di Renzo, G; Iannotti, E; Saggese, ML	1

Other Studies

1 other study(ies) available for quinazolines and bis(1,3-diethylthiobarbiturate)trimethineoxonol

Article	Year
The A1 agonist CCPA reduced bisoxonol-monitored membrane potential depolarization elicited by high K+ in cerebrocortical nerve endings. Biochimica et biophysica acta, 1995, Oct-04, Volume: 1239, Issue:1 Topics: Adenosine; Animals; Cerebral Cortex; Fluorescent Dyes; Male; Membrane Potentials; Nerve Endings; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Synaptosomes; Thiobarbiturates; Triazoles; Veratridine; Xanthines	1995

Article

Year

The A1 agonist CCPA reduced bisoxonol-monitored membrane potential depolarization elicited by high K+ in cerebrocortical nerve endings.

Biochimica et biophysica acta, 1995, Oct-04, Volume: 1239, Issue:1

Topics: Adenosine; Animals; Cerebral Cortex; Fluorescent Dyes; Male; Membrane Potentials; Nerve Endings; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Synaptosomes; Thiobarbiturates; Triazoles; Veratridine; Xanthines

1995